Proteomics

Dataset Information

0

TMT analysis of tissue proteomics in bevacizumab-resistant xenograft tumor tissuein nude mice


ABSTRACT: TMT proteomics was used to detect the difference in protein expression of bevacizumab-resistant xenograft tumor tissue in nude mice.

INSTRUMENT(S): Q Exactive

ORGANISM(S): Mus Musculus (mouse)

TISSUE(S): Colon

DISEASE(S): Colon Cancer

SUBMITTER: Yuning Lin  

LAB HEAD: Dongmei Zhang

PROVIDER: PXD030202 | Pride | 2022-10-13

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
F1.raw Raw
F10.raw Raw
F11.raw Raw
F12.raw Raw
F13.raw Raw
Items per page:
1 - 5 of 21
altmetric image

Publications


Vessel co-option has been demonstrated to mediate colorectal cancer liver metastasis (CRCLM) resistance to antiangiogenic therapy. The current mechanisms underlying vessel co-option have mainly focused on "hijacker" tumor cells, whereas the function of the "hijackee" sinusoidal blood vessels has not been explored. Here, we found that the occurrence of vessel co-option in bevacizumab-resistant CRCLM xenografts was associated with increased expression of fibroblast activation protein α (FAPα) in t  ...[more]

Similar Datasets

2015-09-20 | E-GEOD-64837 | biostudies-arrayexpress
2012-03-26 | E-GEOD-36820 | biostudies-arrayexpress
2008-06-11 | E-GEOD-10957 | biostudies-arrayexpress
2014-02-14 | E-GEOD-54974 | biostudies-arrayexpress
2015-11-04 | E-GEOD-45904 | biostudies-arrayexpress
2012-03-15 | E-GEOD-26308 | biostudies-arrayexpress
2013-07-31 | E-GEOD-49353 | biostudies-arrayexpress
2010-12-29 | E-GEOD-26335 | biostudies-arrayexpress
2009-02-26 | E-GEOD-11910 | biostudies-arrayexpress
2019-04-23 | PXD011485 | Pride